Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Biomerica's H pylori test:

This article was originally published in Clinica

Executive Summary

Biomerica has received CE mark approval for the Fortel HP Ulcer Test, its home diagnostic for Helicobacter pylori, a bacterium responsible for over 85% of gastric ulcers. The firm, based in Newport Beach, California, said that it was already in discussions with several significant distributors for the 15-minute one-step blood test. H pylori infection is widespread, affecting over one billion people worldwide. Nearly all duodenal ulcer patients and over 80% of stomach ulcer patients are infected with the bacterium, and it is estimated that the worldwide anti-ulcer market is worth over $9.5bn.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT049476

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel